Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells
Journal of Pharmacology and Experimental Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103577 - 103577
Published: April 1, 2025
Glucocorticoid
receptor
(GR)
plays
important
roles
in
many
diseases
including
prostate
cancer.
Intracellular
shuttling
of
GR
is
thought
to
be
an
mechanism
regulating
its
localization
the
nucleus
required
for
transactivation
target
genes.
Here,
using
fluorescent
microscopy
coupled
with
pulse-chase
and
nucleocytoplasmic
fractionation
western
blot,
we
provided
evidence
that
can
imported
then
degraded
absence
ligand.
We
also
showed
nuclear
was
stabilized
by
glucocorticoid
hormone
withdrawal
caused
degradation,
but
not
export.
Further
analysis
ubiquitination
occurred
predominantly
compared
cytoplasm
suppressed
glucocorticoids.
Using
small
interfering
RNA
knockdown,
loss
E3
ligase
CHIP
significantly
inhibited
degradation
nucleus,
while
enhancing
expression
gene
SGK1.
These
findings
support
updated
model
trafficking
a
1-way
trip,
involving
import
Future
studies
should
focus
on
defining
mechanisms
which
may
lead
novel
approaches
modulate
function
disease
treatment.
SIGNIFICANCE
STATEMENT:
This
study
suggests
will
guide
future
localization,
Language: Английский
Urolithins: Emerging natural compound targeting castration-resistant prostate cancer (CRPC)
Biomedicine & Pharmacotherapy,
Journal Year:
2025,
Volume and Issue:
187, P. 118058 - 118058
Published: April 19, 2025
Language: Английский
Molecular mechanism of the crosstalk between glucocorticoid receptor (GR) and hypoxia-inducible factor 3α (HIF-3α) pathways
Marine Life Science & Technology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: June 4, 2025
Language: Английский
Steroid receptor-assisted loading modulates transcriptional responses in prostate cancer cells
Johannes Hiltunen,
No information about this author
Laura Helminen,
No information about this author
Niina Aaltonen
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
ABSTRACT
Steroid
receptors
are
involved
in
a
wide
array
of
crosstalk
mechanisms
that
regulate
diverse
biological
processes,
with
significant
implications
diseases,
particularly
cancers.
In
prostate
cancer,
indirect
between
androgen
receptor
(AR)
and
glucocorticoid
(GR)
is
well-documented,
where
GR
replaces
antiandrogen-inactivated
AR
becoming
the
disease
driver.
However,
existence
impact
direct
chromatin
cancer
have
remained
elusive.
Our
genome-wide
investigations
reveal
activation
significantly
expands
binding.
Mechanistically,
induces
remodeling
closed
sites,
facilitating
binding
to
inaccessible
sites.
Importantly,
coactivation
results
distinct
transcriptional
responses
at
both
cell
population
single-cell
levels.
Intriguingly,
pathways
affected
by
these
changes
generally
associated
improved
patient
survival.
Thus,
yields
markedly
different
outcomes
from
known
role
circumventing
blockade
antiandrogens.
Language: Английский